Willie Quinn | Chief Financial Officer & Senior Vice President, Corporate Development |
Dayton Misfeldt | Interim Chief Executive Officer |
Judy Fox | Chief Scientific Officer |
Par Hyare | Senior Vice President Commercial |
Deepali Suri | Vice President, Clinical Operations |
Marc Frahm | Colin |
Hartaj Singh | Oppenheimer |
Jim Birchenough | Wells Fargo Securities |
Yanan Zhu | Wells Fargo Securities |
Good afternoon, ladies and gentlemen, and welcome to the Sunesis Pharmaceuticals Second Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the call over to your host Mr.